|
|
||||||||
Technical Developments |
1 From the Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research, Surrey, England (A.P.P., M.O.L., A.S.K.D.J.); and Royal Marsden National Health Service Trust, Sutton, England (D.J.C.). Received September 9, 2002; revision requested November 18; revision received January 6, 2003; accepted February 25. Supported by Cancer Research UK grant SP1780/0103 and Medical Research Council grant GU 78/6400. Address correspondence to A.S.K.D.J., GlaxoSmithKline Pharmaceuticals, Building 5, Floor 1, Room 13, 890995 Greenford Rd, London UB6 0HE, England (e-mail: andrzej.s.dzik-jurasz@gsk.com).
Proton (hydrogen 1) magnetic resonance (MR) spectroscopy was used to study model and porcine bile in vitro. The method was subsequently developed to facilitate the acquisition of in vivo 1H MR spectra from the gallbladder bile of 10 human volunteers. Signals attributable to phosphotidylcholine and conjugated bile acid protons were observed in eight of the 10 volunteers. Phosphotidylcholine concentrations were estimated, and five values (mean = 35.8 mmol/L, SD = 9.8) were within the expected range of levels in human bile. Findings in this preliminary investigation indicate that human gallbladder bile can be qualitatively and quantitatively studied noninvasively with 1H MR spectroscopy.
© RSNA, 2003
Index terms: Bile ducts, MR, 768.12145 Gallbladder, MR, 762.12145
This article has been cited by other articles:
![]() |
A Dzik-Jurasz The development and application of functional nuclear magnetic resonance to in vivo therapeutic anticancer research: 2002 Sir Godfrey Hounsfield lecture delivered at the President's Day, Manchester Br. J. Radiol., April 1, 2004; 77(916): 296 - 307. [Abstract] [Full Text] [PDF] |
||||